# A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia

> **NCT00796783** · — · TERMINATED · sponsor: **Corcept Therapeutics** · enrollment: 2 (actual)

## Conditions studied

- Cushing's Syndrome

## Interventions

- **DRUG:** Cushing's syndrome confirmation

## Key facts

- **NCT ID:** NCT00796783
- **Lead sponsor:** Corcept Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2009-02
- **Primary completion:** 2010-06
- **Final completion:** —
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2014-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00796783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00796783, "A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00796783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*